Law360, New York (January 16, 2008) -- Impax Laboratories Inc. is challenging Medicis Pharmaceutical Corp.'s patent for a popular acne medication in hopes of launching a generic version of the drug.
Impax announced on Tuesday that it had filed a lawsuit against Medicis in the U.S. District Court for the Northern District of California to fend off a patent challenge for...
